Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel

Combinatorial therapeutic strategies to eradicate tumors can be superior to a single therapeutic modality. Docetaxel (DT) has been approved for the treatment of local or metastasized breast cancer alone or in combination with other chemotherapeutic agents. Thymoquinone (TQ) originated from the seeds...

Descripción completa

Detalles Bibliográficos
Autores principales: Odeh, Fadwa, Naffa, Randa, Azzam, Hanan, Mahmoud, Ismail S., Alshaer, Walhan, Al Bawab, Abeer, Ismail, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895652/
https://www.ncbi.nlm.nih.gov/pubmed/31844767
http://dx.doi.org/10.1016/j.heliyon.2019.e02919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895652/
https://www.ncbi.nlm.nih.gov/pubmed/31844767
http://dx.doi.org/10.1016/j.heliyon.2019.e02919

Ejemplares similares